AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024 09:00 ET
|
AVITA Medical
AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.
AVITA Medical to Host Investor Webinar Briefing
December 04, 2023 09:00 ET
|
AVITA Medical
AVITA Medical to host investor webinar briefing on December 5, 2023, at 2:00 p.m. PST. Register at https://rebrand.ly/Dec2023webinar
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023 16:15 ET
|
AVITA Medical
VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical Updates Full Year 2023 Guidance
November 20, 2023 16:15 ET
|
AVITA Medical
VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
November 09, 2023 16:01 ET
|
AVITA Medical
VALENCIA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
November 09, 2023 09:00 ET
|
AVITA Medical
AVITA Medical announced it has entered into a distribution agreement with PolyMedics Innovations, to strategically expand its global presence to Europe.
AVITA Medical to Announce Third Quarter 2023 Financial Results
October 19, 2023 16:05 ET
|
AVITA Medical
VALENCIA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth Initiatives
October 18, 2023 09:00 ET
|
AVITA Medical
AVITA Medical announces third quarter 2023 preliminary commercial revenue of $13.5 million and secures up to $90 million of non-dilutive debt financing.
AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma
September 25, 2023 08:00 ET
|
AVITA Medical
VALENCIA, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical to Present at the Cantor Global Healthcare Conference
September 21, 2023 16:30 ET
|
AVITA Medical
VALENCIA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...